# Progress Note 06 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Sun Yat-sen (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET016-SYN
- Date: 2026-09-21
- Fictional facility: St. Posthumous Health Center
- Fictional author: Wen-Li Huang, MD
- Calendar frame: modern shifted

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning) on the same day

## Chief complaint

Periodic adult preventive visit. **S**

## History of present illness

Mr. Sun is a 57-year-old physician by training and political leader who comes for his yearly preventive visit, timed with the day-8 infusion of cycle 6, which he had this morning. The cold of three weeks ago cleared within a week without fever. He has been working most days and has kept his weight steady with the dietitian's advice. He meets the palliative care team every three to four weeks and has talked with them about what matters most to him. He asked which preventive services still make sense for him now, and wants the vaccines that protect him during treatment. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 57 |
| Cancer treatment | Cycle 6 of gemcitabine, cisplatin and durvalumab; day-8 dose today |
| Recent illness | Cold cleared within a week |
| Weight | Steady at about 59 kg |
| His question | Which preventive services still make sense now |

## Health risk assessment

Completed by the patient on the clinic tablet before the visit and reviewed with him by Dr. Huang. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Fair; tired in the afternoons, but working most days |
| Psychosocial | Supported by colleagues and his household; talks openly with the palliative care team |
| Substance use | Alcohol rarely, at formal dinners; none since starting treatment; no drugs |
| Tobacco | Never smoked |
| Physical activity | Walks 30 minutes most days |
| Nutrition | Small frequent meals and a protein drink each day, as the dietitian advised |
| Sleep | Six to seven hours; occasional night waking |
| Infection precautions | Hand hygiene; avoids crowds in the week after day-8 doses; has a thermometer |
| Safety at home | Feels safe; smoke alarm working; no firearm at home |
| Road safety | Wears a seat belt; is driven to most meetings |
| Activities of daily living | Independent |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Afternoon tiredness; no fever; weight steady |
| Eyes | Negative | Reading glasses; no change |
| Ears, nose, mouth, and throat | Negative | Cold resolved; no ringing in the ears or hearing change; no mouth sores |
| Cardiovascular | Negative | No chest pain or leg swelling |
| Respiratory | Negative | Cough gone; no breathlessness |
| Gastrointestinal | Negative | Mild nausea on the two days after each infusion, eased by ondansetron; no jaundice; ache under the right ribs 1 of 10 |
| Genitourinary | Negative | No urinary symptoms |
| Musculoskeletal | Negative | No joint pain |
| Integumentary | Negative | No rash or itching |
| Neurological | Negative | No numbness or tingling |
| Endocrine | Negative | No heat or cold intolerance, thirst, or excess urination |
| Psychiatric | Negative | Mood steady; PHQ-2 score 1 |

12 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, two tablets by mouth every 8 hours as needed for right upper abdominal ache; no more than 3,000 mg a day **S**
- Gemcitabine 1,000 mg/m2 (1,660 mg) intravenous infusion on days 1 and 8 of each 21-day cycle **S**
- Cisplatin 25 mg/m2 (41 mg) intravenous infusion on days 1 and 8 of each 21-day cycle **S**
- Durvalumab 1,500 mg intravenous infusion on day 1 of each 21-day cycle **S**
- Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours as needed for nausea **S**

## Allergies

- No known allergy **S**

## Objective

BP 122/76 mmHg; pulse 80 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 59.4 kg; BMI 21.8 kg/m². All vital signs are synthetic.

PHQ-2: 1. All results are synthetic.

## Change since baseline

- PHQ-2: 1 at baseline, 1 at this visit **S**

## Immunizations given today

- Influenza vaccine, 2026-2027 season (inactivated) **S**
- COVID-19 vaccine, 2026-2027 formula **S**
- Pneumococcal conjugate vaccine (PCV20), for immunosuppression by chemotherapy **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Thin but well; weight 59.4 kg, BMI 21.8; blood pressure 122/76, pulse 80 |
| Ears, nose, mouth, and throat | Throat normal; no thrush; whispered voice heard at arm's length in both ears |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Liver edge firm, 2 cm below the right costal margin, smaller than at diagnosis; no ascites; no tenderness |
| Skin | Port site clean; no jaundice or rash |
| Psychiatric | Composed, engaged, precise in his questions |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the prevention plan adjusted to his advanced cancer, as he asked. Vaccines that protect him during treatment are given today. Cancer screening tests whose benefit takes years to appear (colon, prostate) are not offered now because of his metastatic cancer, after discussion with him. He has never had an HIV test and agreed to one. **S**
   - Inactivated influenza, COVID-19 and PCV20 pneumococcal vaccines today.
   - First recombinant zoster vaccine dose at the next visit.
   - HIV test today.
   - No live vaccines while on treatment.
   - Next preventive visit in one year.
2. **Gallbladder adenocarcinoma, stage IVB, on chemoimmunotherapy** (C23). Liver edge smaller on examination; weight steady; ECOG 1. Treatment continues with Dr. Choi. **S**
   - Cycle 7 as booked; restaging CT after cycle 7.
3. **Acute viral upper respiratory infection** (J06.9). Resolved. **S**
   - No further action.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 122/76 mmHg |
| Depression screening | Completed today | PHQ-2 score 1; PHQ-9 tracked at oncology visits |
| Unhealthy alcohol use screening | Completed today | Drinks rarely; none since treatment began |
| Tobacco use | Completed today | Never smoked |
| Colorectal cancer screening | Not indicated | Never screened; with metastatic gallbladder cancer the benefit of screening would not be realized, and he agreed not to pursue it now |
| Prostate cancer screening | Not indicated | Discussed; not offered while he has metastatic cancer |
| Lung cancer screening | Not indicated | Never smoked; he has CT scans of the chest every 2 to 3 months for his cancer |
| Diabetes screening | Not indicated | Not overweight; glucose 98 mg/dL at intake |
| HIV screening | Ordered | Never tested; once-in-a-lifetime test drawn today with his agreement |
| Hepatitis C screening | Up to date | Antibody negative at intake |
| Hepatitis B screening | Up to date | Resolved infection at intake; HBV DNA monitored during treatment; vaccination not needed |
| Influenza vaccine | Completed today | Inactivated vaccine given today |
| COVID-19 vaccine | Completed today | Given today; immunocompromised adults may need an additional dose, to be reviewed with the oncology team |
| Pneumococcal vaccine | Completed today | PCV20 given today because chemotherapy suppresses his immunity; no further pneumococcal dose needed |
| Zoster vaccine | Due | Recombinant zoster vaccine recommended for immunocompromised adults; first dose at the next visit, second one to two months later |
| Tetanus, diphtheria, and pertussis | Up to date | Tdap after a hand cut five years ago |

## Advance care planning

Voluntary advance care planning discussion of about 25 minutes, with his consent, building on his conversations with the palliative care team. He named a health care agent, recorded in the confidential part of the chart and not named here. He wants to be told everything plainly and to make his own decisions while he can. He wants treatment that lets him keep working and thinking clearly; if his illness reached the point where he could no longer communicate and there was no prospect of recovery, he would not want to be kept alive on machines and would want comfort care. He chose to wait before completing a portable medical order form and will revisit it with the palliative care team. To be revisited when treatment changes. **S**

## Guideline basis

- Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update (2017), American Society of Clinical Oncology (Journal of Clinical Oncology)
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Colorectal Cancer: Screening (2021), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Medical Condition and Other Indication (2026), Centers for Disease Control and Prevention

## Follow-up

- HIV result by phone. Cycle 7 as booked. Oncology visit before cycle 8 with restaging CT; first zoster vaccine dose then. Next preventive visit in one year. **S**
- Next scheduled visit 2026-10-26: before cycle 8: restaging CT, toxicity review, low magnesium, and the plan for maintenance durvalumab. **S**
